Suppr超能文献

肾移植晚期移植物丢失的原因:慢性移植物功能障碍、死亡及其他因素。

Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.

作者信息

Kreis H A, Ponticelli C

机构信息

Hĵpital Necker, University of Paris, France.

出版信息

Transplantation. 2001 Jun 15;71(11 Suppl):SS5-9.

Abstract

CAN and patient death with allograft function are the 2 major causes of renal allograft loss after the first year, accounting for 80% or more of cases. According to current estimates from the United Network for Organ Sharing (UNOS), the half-lives for renal allografts performed in 1995 and 1996 from living and cadaveric donors are 15.3 and 10.4 years, respectively (2). Consequently, much attention has been focused on better understanding the causes of CAN and patient death with a functioning allograft in an attempt to improve long-term renal allograft outcomes. Although the pathogenesis of CAN is not completely understood, we know that CAN involves alloantigen-dependent and alloantigen-independent factors that combine to produce chronic deterioration of renal allograft function. CVD is the most frequent cause of death in renal transplant recipients, and we need to address its well-established risk factors in that population. Among other improvements, changes in current immunosuppressive protocols may increase long-term renal allograft survival and function by decreasing both the risk of CAN and the risk of CVD.

摘要

慢性移植物肾病(CAN)和伴有移植肾功能的患者死亡是肾移植术后第一年移植物丢失的两大主要原因,占病例的80%或更多。根据器官共享联合网络(UNOS)目前的估计,1995年和1996年来自活体和尸体供体的肾移植的半衰期分别为15.3年和10.4年(2)。因此,为了改善肾移植的长期预后,人们将大量注意力集中在更好地了解CAN的病因和伴有功能良好移植物的患者死亡原因上。尽管CAN的发病机制尚未完全明了,但我们知道CAN涉及同种抗原依赖性和非同种抗原依赖性因素,这些因素共同导致肾移植功能的慢性恶化。心血管疾病(CVD)是肾移植受者最常见的死亡原因,我们需要解决该人群中已明确的危险因素。在其他改进措施中,目前免疫抑制方案的改变可能通过降低CAN风险和CVD风险来提高肾移植的长期存活率和功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验